Wells Fargo Reiterates Overweight Rating on Dianthus Therapeutics (DNTH)
Tweet Send to a Friend
Wells Fargo reiterated an Overweight rating and $135.00 price ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
